Cite
Lopez-Sendon JL, Cyr DD, Mark DB, et al. Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial. Eur Heart J. 2022;43(2):148-149doi: 10.1093/eurheartj/ehab509.
Lopez-Sendon, J. L., Cyr, D. D., Mark, D. B., Bangalore, S., Huang, Z., White, H. D., Alexander, K. P., Li, J., Nair, R. G., Demkow, M., Peteiro, J., Wander, G. S., Demchenko, E. A., Gamma, R., Gadkari, M., Poh, K. K., Nageh, T., Stone, P. H., Keltai, M., Sidhu, M., Newman, J. D., Boden, W. E., Reynolds, H. R., Chaitman, B. R., Hochman, J. S., Maron, D. J., & O'Brien, S. M. (2022). Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial. European heart journal, 43(2), 148-149. https://doi.org/10.1093/eurheartj/ehab509
Lopez-Sendon, Jose L, et al. "Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial." European heart journal vol. 43,2 (2022): 148-149. doi: https://doi.org/10.1093/eurheartj/ehab509
Lopez-Sendon JL, Cyr DD, Mark DB, Bangalore S, Huang Z, White HD, Alexander KP, Li J, Nair RG, Demkow M, Peteiro J, Wander GS, Demchenko EA, Gamma R, Gadkari M, Poh KK, Nageh T, Stone PH, Keltai M, Sidhu M, Newman JD, Boden WE, Reynolds HR, Chaitman BR, Hochman JS, Maron DJ, O'Brien SM. Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial. Eur Heart J. 2022 Jan 13;43(2):148-149. doi: 10.1093/eurheartj/ehab509. PMID: 34514494.
Copy
Download .nbib